Department of Microbiome Research
University Hospital Erlangen
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Ulmenweg 18
91054 Erlangen
- +49-151-40134646
- stephan.rosshart@uk-erlangen.de
- Homepage
Current position
W3 Professor, Head of the Department of Microbiome Research, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Academic training
| 2003 - 2009 | Study of Medicine in Freiburg with electives in the USA (Memorial Sloan-Kettering Cancer Center New York) and Switzerland (Kantons Hospital Frauenfeld) |
| 2001 - 2003 | Study of Biology in Freiburg |
Scientific training
| 2009 | Dissertation in Medicine, University of Freiburg (Supervisor: Prof. Dr. Hanspeter Pircher) |
Postgraduate positions
| since 2023 | W3 Professor, Head of the Department of Microbiome Research, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |
| since 2021 | Emmy Noether group leader and head of the gnotobiotic mouse facility, Department of Medicine II, Medical Center – University of Freiburg |
| 2019 - 2021 | Group leader and head of the gnotobiotic mouse facility, clinical fellow, Department of Medicine II, Medical Center – University of Freiburg |
| 2013 - 2019 | Postdoctorate (NIH fellowship), Immunology Section, Liver Diseases Branch, NIDDK, NIH, Bethesda, MD, USA |
| 2009 - 2013 | Clinical fellow, Department of Medicine II, Medical Center – University of Freiburg |
Miscellaneous (Honors, Awards)
| 2021 | DFG Emmy Noether-Program |
| 2020 | DFG IMM-PACT Clinician Scientist-Programm, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Germany |
| 2017 | Fellows Award for Research Excellence (FARE), National Institutes of Health (NIH), Bethesda, MD, USA |
| 2013 & 2015 | NIDDK Visiting Fellowship Award, National Institutes of Health (NIH), Bethesda, MD, USA |
| 2010 | Young Investigator Award for Experimental and Clinical Cancer Research by Pfizer Company, Freiburg, Germany |
| 2000 | Award for an outstanding High School Diploma by the EnergieDienst GmbH, Weil am Rhein, Germany |
link to all publications from S. Rosshart: Pubmed
Publications based on CRC1160 funding
Mann J, Runge S, Schell C, Gräwe K, Thoulass G, Lao J, Ammann S, Grün S, König C, Berger SA, Hild B, Aichele P, Rosshart SP, Ehl S. 2024. The Microbiome Modifies Manifestations of Hemophagocytic Lymphohistiocytosis in Perforin-Deficient Mice. Eur J Immunol. 2024 Nov 16:e202451061. doi: 10.1002/eji.202451061.
Torcellan T, Friedrich C, Doucet-Ladevèze R, Ossner T, Solé VV, Riedmann S, Ugur M, Imdahl F, Rosshart SP, Arnold SJ, Gomez de Agüero M, Gagliani N, Flavell RA, Backes S, Kastenmüller W, Gasteiger G. 2024. Circulating NK cells establish tissue residency upon acute infection of skin and mediate accelerated effector responses to secondary infection. Immunity. 2024 Jan 9;57(1):124-140.e7. doi: 10.1016/j.immuni.2023.11.018.
Ma J, Urgard E, Runge S, Classon CH, Mathä L, Stark JM, Cheng L, Álvarez JA, von Zedtwitz S, Baleviciute A, Martinez Hoyer S, Li M, Gernand AM, Osbelt L, Bielecka AA, Lesker TR, Huang HJ, Vrtala S, Boon L, Beyaert R, Adner M, Martinez Gonzalez I, Strowig T, Du J, Nylén S, Rosshart SP, Coquet JM. 2023. Laboratory mice with a wild microbiota generate strong allergic immune responses. Sci Immunol. 8(87):eadf7702. doi: 10.1126/sciimmunol.adf7702.
Zeiser R, Warnatz K, Rosshart S, Sagar, Tanriver Y. 2022. GVHD, IBD and primary immunodeficiencies: The gut as a target of immunopathology resulting from impaired immunity. Eur J Immunol. 52(9):1406-1418. doi: 10.1002/eji.202149530.
